MedPath

A comparative trial on eradicative and clinical effects of Kampo formulas for multiply-resistant organisms in elderly bacterial carriers.

Not Applicable
Conditions
Elderly bacterial carriers with multiply-resistant organisms.
Registration Number
JPRN-UMIN000004549
Lead Sponsor
niversity of Toyama
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
74
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients with severe diseases whose serum albumin level is under 2.7 g/dl or concentration of hemoglobin is under 9.0 g/dl. 2. Patients with infections who continue the fever above 38 degrees C.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Eradicative rates of multiply-resistant organisms.
Secondary Outcome Measures
NameTimeMethod
K-cell activity
© Copyright 2025. All Rights Reserved by MedPath